A novel stem cell-based platform for generating pig macrophages for African Swine Fever Virus (ASFV) vaccine production

Project Details

StatusFinished
Effective start/end date1/04/20 → 30/06/21

Funding

  • UK industry, commerce and public corporations: £42,654.00